Absci (ABSI) Net Cash Flow (2020 - 2026)
Absci's (ABSI) quarterly Net Cash Flow came in at -$11.4 million in Q1 2026, down 292.67% year-on-year from $5.9 million in Q1 2025, and down 96.6% quarter-over-quarter from -$5.8 million in Q4 2025.
Absci (ABSI) Net Cash Flow (2020 - 2026) Analysis & Trends
Absci has disclosed Net Cash Flow across 7 years of filings, most recently posting -$11.4 million for Q1 2026.
- Net Cash Flow for Q1 2026 came in at -$11.4 million, down 292.67% year-over-year; the trailing twelve-month figure through Mar 2026 was -$54.4 million (down 346.86% YoY), and the FY2025 annual result was -$37.1 million, down 18.07% from the prior year.
- Net Cash Flow came in at -$11.4 million for Q1 2026 at Absci, down from -$5.8 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $49.7 million in Q2 2023 to a low of -$98.7 million in Q3 2022.
- The 5-year median for Net Cash Flow is -$11.4 million (2026), against an average of -$15.9 million.
- Across the five-year window, Net Cash Flow soared 277.63% in 2023 and plunged 422.74% in 2025, its largest moves.
- Absci's Net Cash Flow stood at -$47.4 million in 2022, then jumped by 105.92% to $2.8 million in 2023, then advanced by 9.43% to $3.1 million in 2024, then tumbled by 289.0% to -$5.8 million in 2025, then sank by 96.6% to -$11.4 million in 2026.
- The last three Net Cash Flow figures came in at -$11.4 million (Q1 2026), -$5.8 million (Q4 2025), and -$28.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | -11.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.39 Mn |
| Mar 31, 2026 | -11.39 Mn |
| Dec 31, 2025 | -5.79 Mn |
| Dec 31, 2025 | -5.79 Mn |
| Sep 30, 2025 | -28.42 Mn |
| Sep 30, 2025 | -28.42 Mn |
| Jun 30, 2025 | -8.84 Mn |
| Jun 30, 2025 | -8.84 Mn |
| Mar 31, 2025 | 5.91 Mn |
| Mar 31, 2025 | 5.91 Mn |
| Dec 31, 2024 | 3.07 Mn |
| Dec 31, 2024 | 3.07 Mn |
| Sep 30, 2024 | -5.44 Mn |
| Sep 30, 2024 | -5.44 Mn |
| Jun 30, 2024 | -15.72 Mn |
| Jun 30, 2024 | -15.72 Mn |
| Mar 31, 2024 | -13.36 Mn |
| Mar 31, 2024 | -13.36 Mn |
| Dec 31, 2023 | 2.80 Mn |
| Dec 31, 2023 | 2.80 Mn |